Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Moshe Yeshurun; Myriam Labopin; Didier Blaise; Jan J Cornelissen; Henrik Sengeloev; Lars Vindelov; Juergen Kuball; Patrice Chevallier; Charles Craddock; Gerard Socie; Karin Bilger; Harry C Schouten; Nathalie Fegueux; Hakan Goker; Johan Maertens; Donald Bunjes; Renate Arnold; Arnon Nagler; Mohamad Mohty

doi:10.1002/cncr.28498

Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Moshe Yeshurun, Myriam Labopin, Didier Blaise, Jan J Cornelissen, Henrik Sengeloev, Lars Vindelov, Juergen Kuball, Patrice Chevallier, Charles Craddock, Gerard Socie, Karin Bilger, Harry C Schouten, Nathalie Fegueux, Hakan Goker, Johan Maertens, Donald Bunjes, Renate Arnold, Arnon Nagler, Mohamad Mohty

32 Citationer (Scopus)

Abstract

The objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).

Originalsprog	Engelsk
Tidsskrift	Cancer
Vol/bind	120
Udgave nummer	6
Sider (fra-til)	855-63
ISSN	0008-543X
DOI	https://doi.org/10.1002/cncr.28498
Status	Udgivet - 2014

Adgang til dokumentet

10.1002/cncr.28498

Fingeraftryk

Dyk ned i forskningsemnerne om 'Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Yeshurun, M., Labopin, M., Blaise, D., Cornelissen, J. J., Sengeloev, H., Vindelov, L., Kuball, J., Chevallier, P., Craddock, C., Socie, G., Bilger, K., Schouten, H. C., Fegueux, N., Goker, H., Maertens, J., Bunjes, D., Arnold, R., Nagler, A., & Mohty, M. (2014). Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Cancer, 120(6), 855-63. https://doi.org/10.1002/cncr.28498

Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. / Yeshurun, Moshe; Labopin, Myriam; Blaise, Didier et al.
I: Cancer, Bind 120, Nr. 6, 2014, s. 855-63.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Yeshurun, M, Labopin, M, Blaise, D, Cornelissen, JJ, Sengeloev, H, Vindelov, L, Kuball, J, Chevallier, P, Craddock, C, Socie, G, Bilger, K, Schouten, HC, Fegueux, N, Goker, H, Maertens, J, Bunjes, D, Arnold, R, Nagler, A & Mohty, M 2014, 'Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation', Cancer, bind 120, nr. 6, s. 855-63. https://doi.org/10.1002/cncr.28498

Yeshurun M, Labopin M, Blaise D, Cornelissen JJ, Sengeloev H, Vindelov L et al. Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Cancer. 2014;120(6):855-63. doi: 10.1002/cncr.28498

Yeshurun, Moshe ; Labopin, Myriam ; Blaise, Didier et al. / Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission : A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. I: Cancer. 2014 ; Bind 120, Nr. 6. s. 855-63.

@article{c6422c1c260f48269f006df9cd3be24e,

title = "Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation",

abstract = "The objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).",

author = "Moshe Yeshurun and Myriam Labopin and Didier Blaise and Cornelissen, {Jan J} and Henrik Sengeloev and Lars Vindelov and Juergen Kuball and Patrice Chevallier and Charles Craddock and Gerard Socie and Karin Bilger and Schouten, {Harry C} and Nathalie Fegueux and Hakan Goker and Johan Maertens and Donald Bunjes and Renate Arnold and Arnon Nagler and Mohamad Mohty",

note = "{\textcopyright} 2013 American Cancer Society.",

year = "2014",

doi = "10.1002/cncr.28498",

language = "English",

volume = "120",

pages = "855--63",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission

T2 - A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

AU - Yeshurun, Moshe

AU - Labopin, Myriam

AU - Blaise, Didier

AU - Cornelissen, Jan J

AU - Sengeloev, Henrik

AU - Vindelov, Lars

AU - Kuball, Juergen

AU - Chevallier, Patrice

AU - Craddock, Charles

AU - Socie, Gerard

AU - Bilger, Karin

AU - Schouten, Harry C

AU - Fegueux, Nathalie

AU - Goker, Hakan

AU - Maertens, Johan

AU - Bunjes, Donald

AU - Arnold, Renate

AU - Nagler, Arnon

AU - Mohty, Mohamad

PY - 2014

Y1 - 2014

N2 - The objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).

AB - The objective of the current study was to investigate the role of postremission consolidation chemotherapy before reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (alloSCT) for patients with acute myeloid leukemia (AML) in first complete remission (CR1).

U2 - 10.1002/cncr.28498

DO - 10.1002/cncr.28498

M3 - Journal article

C2 - 24338939

SN - 0008-543X

VL - 120

SP - 855

EP - 863

JO - Cancer

JF - Cancer

IS - 6

ER -